ABSTRACT Plasma levels of adrenaline and noradrenaline during and after submaximal exercise in patients with bronchial asthma were investigated. Three groups were studied comprising 10 patients with exercise-induced bronchoconstriction (EIB), 1Oasthmatic patients without EIB and four normal control subjects. Plasma catecholamines were measured at rest, at the end of exercise, and five and 15 minutes after exercise. Changes in airway resistance were assessed by measuring peak expiratory flow rate. Significant differences in catecholamine levels between reacting and non-reacting patients were found. In 10 patients developing EIB adrenaline and noradrenaline levels had risen significantly by the end of exercise and remained elevated up to the fifth minute of recovery. The rise in catecholamine levels in non-reacting asthmatics was insignificant. In control subjects noradrenaline had increased significantly by the end of exercise.
Despite many years of investigation some aspects of exercise-induced bronchoconstriction (EIB) remain unclear. Its mechanism is not yet known nor are the reasons for its appearance after completion of exercise rather than during it. It is well known that plasma catecholamine levels increase during physical exercise.' A rise in noradrenaline level depends on the work performed in relation to the maximal oxygen uptake.2 3 Adrenaline level rises only at a very high workload.4 6 Adrenaline is one of the most potent endogenous bronchodilators. Noradrenaline induces a constriction of bronchial smooth muscle. Respective levels and reciprocal relations between adrenaline and noradrenaline during and after physical exercise in patients with bronchial asthma may influence the time of onset and the course of EIB.
The aim of this study was to investigate the changes in catecholamine levels during and after exercise in asthmatic patients with and without EIB.
Methods
Twenty patients with atopic asthma were studied. The diagnosis was based on history, positive skin tests, and eosinophilia in the blood or sputum. The patients were divided into two groups according to their response to exercise. The first group comprised 10 patients developing EIB. The second contained asthmatics without EIB. Four healthy members of the medical staff made up the control group. In order to avoid a large range of physical performance between subjects, an age of 39 years was taken as an upper limit for admission to the study.
It was noted in general that patients with EIB had more severe asthma than non-reactors. Their mean basal PEFR was lower, they were using more drugs, two of them were on continuous steroids therapy and they were physically less fit. Non-reactors were on intermittent beta-adrenergic stimulating drugs only. The majority of this group were students regularly performing sporting activity.
Exercise tests were done in a sitting position on a bicycle ergometer. A steady-state submaximal exercise of 10 minutes was performed by each subject, the workload being individually adjusted during preparatory tests to achieve a steady heart rate ranging between 80-90% of predicted maximal heart rate.6 Peak expiratory flow rate was measured in the sitting position at rest and at one, five, and 15 Mean age and heart rate at rest and on exercise (also expressed as a percentage of predicted maximal heart rate) are shown in table 1. Exercise tolerance was lowest in patients with EIB and highest in control subjects. The scatter of exercise heart rate in each group was small averaging 88-89% of the maximal predicted heart rate.6 Table 2 shows change in PEFR and catecholamine levels at rest, on exercise, and after exercise in patients developing bronchospasm. Peak Noradrenaline rose from 0-88 ± 0-21 ug/l to 1-32+0 40 iLg/l (p<0-001). Five minutes after exercise these levels decreased but remained significantly higher than at rest (p<005). Fifteen minutes after exercise they returned to the initial values. Table 3 shows the above-mentioned parameters in asthmatic patients without EIB. There was a small statistically insignificant increase in PEFR after exercise in this group. There was also a small statistically insignificant rise in catecholamine levels at the end of exercise. On recovery these levels had returned to resting values. Table 4 shows changes in PEFR and catecholamine levels induced by exercise in the control subjects. Noradrenaline level rose from 1-15+0-23 ,ag/l at rest to 143+0-27 iig/l on exercise (p<0-01) and fell rapidly to resting levels on recovery.
There was no correlation between catecholamine levels at rest, on exercise, or on recovery except between resting values in the group with EIB (r=0-84) and in the tenth minute of exercise in normal subjects (r=0 9). No correlations were observed in any group between PEFR and adrenaline or noradrenaline separately or together.
Discussion
The study has shown that there were substantial differences in catecholamine levels in asthmatic subjects submitted to physical exercise depending on whether EIB was present or not. Thus an increase in catecholamine levels on exercise and early in the post-exercise phase was found in patients reacting with EIB but no significant change was observed in patients not developing EIB.
Our findings on catecholamine levels in patients with EIB are consistent with previous reports.810 Although these authors also found increased catecholamine levels during and immediately after exercise they doubt that this rise plays a role in the development of EIB. Their opinion is based on the observation that the changes in catecholamine levels in asthmatic patients do not differ from those seen in normal controls,8-10 and that they found no correlation between catecholamine levels and increased airway resistance.9 10 We have not found a paper comparing catecholamine levels in asthmatic patients with and There is some evidence that alpha receptor blockade prevents histamine-induced bronchoconstriction,'4 15 or protects asthmatic patients against EIB. '6 17 Here one might assume that noradrenaline released during exercise stimulates alpha receptors in the bronchial smooth muscles sensitising them to the histamine.
The significant increase in adrenaline levels in patients with EIB not seen in normal controls may have resulted from mental stress. These patients were submitted to at least one preparatory test after which they developed severe bronchospasm which was not reversed for 15 minutes. Anticipation of the same unpleasant sensation may have caused the increase in adrenaline level.
It is difficult to explain why in non-reacting asthmatic patients the noradrenaline level on exercise did not increase significantly as was seen in reactors and control subjects, particularly as the relative heart rates were similar in all three groups. Non-reacting subjects did not receive any treatment that could interfere with catecholamine release or with the rate of elimination of noradrenaline from the circulation. McDermott et al'8 have found that catecholamine release during exercise was higher in older men (mean age 46-8 years) than in younger ones (mean age 25 3 years). Although our non-reacting subjects were younger than reactors and control subjects, the intergroup age differences were probably too small to be responsible for the differences in noradrenaline release.
Apart from being younger the non-reacting subjects also regularly performed physical exercise, whereas the reactors and control subjects led a sedentary life. Davies'9 has shown that the prediction of maximal oxygen uptake from heart rate can be a source of important underestimation. It might be assumed that in spite of the same relative heart rate as the other groups, nonreacting patients were working at lower relative oxygen consumption. Were this the case it may have accounted for the lower noradrenaline increase on exercise. 
